Substance Use Disorder (SUD) Addressing Tobacco Through Evidence – Based Interventions
Frank Vitale dives into how you, as a clinician, can support tobacco cessation when interacting with individuals with those you serve. He takes a physiological and behavioral approach to the "5 A's" (ask, advise, assess, assist, and arrange). He also works through Motivational Interviewing and recognizing stages of change.
- Clinical practice guidelines and interventions for treating tobacco use and dependence
- 5A’s of tobacco cessation
- Assessing client readiness to quit
- Motivational interviewing and change talk
- 5A’s of tobacco cessation
-
Implementing interventions for clients ready to quit
-
3 key elements of counseling
-
Developing a quit plan
-
Facilitating the quitting process
-
-
Drug interactions and pharmacological supports
-
Pharmacokinetic drug interactions
-
Medications for cessation
-
Nicotine replacement therapy
-
Combination pharmacotherapy
-
National Behavioral Health Network for Tobacco & Cancer Control provides resources and tools to help organizations reduce tobacco use and cancer among individuals experiencing mental health and substance use challenged.
- Identifying and implementing evidence- based cessation strategies to engage individuals with mental health and substance use challenges with high rates of tobacco use
- Enhancing motivational interviewing techniques to best engage clients in tobacco cessation attempts
- Increasing knowledge of FDA approved Nicotine Replacement Therapies (NRTs) and other pharmacological supports to best support your clinicians and clients
Frank Vitale, M.A.
National Director of the Pharmacy Partnership for Tobacco Cessation
He has worked in the smoking cessation field since 1987 designing cessation programs, educating over 20,000 health professionals in how to help patients stop tobacco use, and counseling nearly 10,000 patients to quit. He received a B.A. in Liberal Arts from St. Vincent College in 1974 and a Master’s Degree in Psychology from Duquesne University in 1988. He entered the field as a Health Educator, then as Clinic Coordinator for the Lung Health Study, researching the differential effects of smoking cessation and an inhaled medication (Atrovent) on the prevention of COPD in identified high risk individuals. Frank followed this by becoming Project Director of Lung Health Study II. Subsequently he created a six-hour CE program, the International Smoking Cessation Specialist Program, designed to teach pharmacists how to do smoking cessation counseling, writing the patient support booklets that accompany this training as well as all auxiliary materials. This program has been presented throughout the U.S., Puerto Rico, Spain and the United Kingdom. In addition, he contributed content material for the RX for Change curriculum. From 2007- 2012 Frank continued to provide cessation counseling training to pharmacists through various project with the CS2Day program. Recently he designed a cessation training program and intervention protocol for psychologist in Beijing, China as well as for the HY VEE grocery chain in eight Midwestern states. He is currently a Clinical Assistant Professor at Purdue’s College of Pharmacy working on a myriad of projects designed to train pharmacists, physicians, respiratory therapists, and other clinicians interested in adding cessation counseling to their practice.
Course Progress
Course Content
What People Are Saying
The course gave me a better understanding of the difficulties consumers endure concerning the stigma and prejudice of dealing with a mental illness."
